Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Li Auto Inc. May 2025 Delivery Update
-
Skills Canada National Competition 2025, in Regina, Wraps up with a Celebration of National Skills Champions!
-
Actuate Therapeutics Presents Topline Elraglusib Phase 2 Data at ASCO 2025 Annual Meeting: Trial Meets Primary Endpoint of Median Overall Survival and Doubles 1-Year Survival in First-Line Treatment o
-
PFM CRYPTO Launches New 2-Day XRP Cloud Mining Contract in Response to The Surge in Demand from Short-Term Income Investors
-
GA (Int’l) Capital Management Announces Launch of Communication Hubs
-
XRP News: XenDex Presale Ends In 12 Hours, Join Presale Before $XDX Exchange Listing
-
AI Meets XRPL: Nimanode’s $NMA Presale Gains Momentum as AI Agents Set to Transform Web3 Automation
-
XRP News: $XDX Token Developed on XRP Nears Presale End in Just 12 Hours as Analysts Predict Major Surge Upon Exchange Listing
-
Afognak Native Corporation Hires New CEO
-
Gatorade 5v5 Finals Bring Global Youth to Champions League Stage in Munich
-
JAMining Expands FCA-Regulated Cloud Mining Services Amid Surging Crypto Market Activity
-
Double Deposit Bonus, $50 Welcome Bonus & No-KYC 100x Leverage Trading Now Available on BexBack
-
Double Deposit Bonus, $50 Welcome Bonus & No-KYC 100x Leverage Trading Now Available on BexBack
-
Direct Energy Regulated Services Announces Natural Gas Rates for June 2025
-
USW: Trump’s 50% tariffs on steel and aluminum are a direct attack on Canadian jobs — Ottawa must act now
-
Crypto Bubbles Come and Go: How Bitcoin Solaris’s Technology Aims for Stable, Long-Term Appreciation
-
Dignity Made Launches to Fight Trafficking with Ethical Coconut Oil
-
New data show Roche’s Itovebi significantly extended survival in a certain type of HR-positive advanced breast cancer
-
Libtayo® (cemiplimab) Phase 3 Data in the Adjuvant Treatment of Post-Surgical High-Risk Cutaneous Squamous Cell Carcinoma (CSCC) Have Potential to Be Practice-Changing
-
Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer
-
Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer
-
Harbinger Health Showcases Multi-Cancer Early Detection Performance in High-Risk Populations at ASCO 2025
-
Xilio Therapeutics Announces Updated Phase 2 Data for Vilastobart, a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer
-
ImPact Biotech Presents Interim Analysis from Phase 3 ENLIGHTED Study of Padeliporfin VTP in LG UTUC at ASCO 2025
-
Maryland Student Wins NFTE Capital Youth Entrepreneurship Challenge
-
Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma
-
Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde® regimen in metastatic pancreatic adenocarcinoma
-
Investors Mobilize to ‘Free Linqto’ Amid Concerns of Mismanagement
-
WithSecure has completed the transaction of Cyber security consulting divestment to Neqst
-
Trans Mountain Corporation Releases First Quarter 2025 Financial Results
-
New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025
-
Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New
-
Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New
-
NEW WAVE ANNOUNCES Closing of Non-Brokered Private Placement of Units
-
Lancaster Resources Announces Closing Conditions Met for Lake Cargelligo Acquisition
-
Trillion Energy Announces Debt Settlements
-
Data Speaks Officially Launches to Redefine Marketing Measurement for the Digital Era
-
Hydreight Reports 34% Year-Over-Year Q1 Revenue Growth, Improvement in Bottom Line Results, and Delivers Strong Performance Across Verticals
-
APOS Announces $60,000 Sponsorship for Delta Waterfowl to Boost Duck Populations in Alberta
-
EAT & BEYOND ANNOUNCES PROPOSED NAME CHANGE AND UPDATED INVESTMENT POLICY
-
Early Warning Press Release Respecting the Acquisition of Common Shares of RAMM PHARMA Corp.
-
Vortex Energy Corp. Announces Marketing Program
-
Mr. Electric of Wichita Celebrates Customer Service Milestone: Surpasses 600 Google Reviews with Outstanding 4.9-Star Rating
-
Galway Metals Announces Closing of Oversubscribed Private Placement
-
Digi Power X Establishes US$100 Million at-the-Market Equity Program to Accelerate Growth
-
LGI Homes Debuts New CompleteHome™ Plus Section at Star Valley in Tucson, AZ
-
Associa Recognized as a US Best Managed Company
-
First Quantum Provides Update on Cobre Panamá
-
Celularity Receives Nasdaq Notice Regarding Form 10-Q
-
Grupo Aeroportuario del Pacifico Announces Drawdown of Ps. 3,375 Million Credit Facility

